MEA Summary Review: Low Dose Naltrexone (LDN) in ME/CFS | 02 December 2019
MEA Summary Review: Low Dose Naltrexone (LDN) in ME/CFS | 02 December 2019 Read More »
We have updated this research review to include a new study from Finland.
MEA Summary Review: Low Dose Naltrexone (LDN) in ME/CFS | 02 December 2019 Read More »
We have updated this research review to include a new study from Finland.
“The ME Association is delighted to announce that our Ramsay Research Fund has been able to make three major research grants totalling nearly £200,000.”
MEA Summary Review: Differentiating Medical Uncertainty | 21 October 2019 Read More »
We take a closer look at recent research from America that highlights concerns over inappropriate and harmful labelling and advocates for medicine to adopt a more patient-centred approach to care.
It is estimated that more than 580,000 Canadians live with myalgic encephalomyelitis (ME), formerly known as chronic fatigue syndrome.
The long-awaited independent assessment of Dr Myhill’s mitochondrial function test was published earlier this week.
MEA Summary Review: The Role of Mitochondria in ME/CFS | 13 July 2019 Read More »
This latest review looks at energy production, and the ongoing search for clues as to what might be causing problems in ME/CFS.
ME Research Summary: Something In The Blood by Simon McGrath | 27 April 2019 Read More »
Four independent groups have now found that a factor in the blood can affect cell metabolism/mitochondria in ME/CFS.
“There is little scientific credibility in the claim that the psycho-behavioural therapies should be primary treatments for this illness.”
We discuss what the new research means and how the Biobank contribution continues to evolve.
“This is the first report that serum CK concentrations are markedly reduced in severe ME/CFS.”
UK ME Biobank: Dr Luis Nacul appointed to new position in Canada | 05 April 2019 Read More »
Dr Luis Nacul has been appointed as Medical Director of the Complex Chronic Diseases Program in British Columbia.
MEA Summary Review: Assessing PEM – The characteristic symptom of ME/CFS | 25 March 2019 Read More »
Latest research analysis is hoped will lead to a definitive definition and will ultimately provide a validated clinical assessment tool.
Abnormalities in energy production would seem to occur ‘upstream’ of the mitochondria.
Evidence could support the involvement of oxidative stress, inflammation and hypoxia in ME/CFS.
MEA Summary Review: Study suggests brain inflammation in ME/CFS | 15 January 2019 Read More »
The latest study from Jarred Younger reports on brain temperature and neuroinflammation in ME/CFS.
New research indicates that handgrip strength may be a good diagnostic tool for ME/CFS.
Charlotte explains the methods and results from this latest research from Dr Morten’s team in Oxford.
The Times: Call for review of ‘flawed’ ME research in Lancet letter | 21 August 2018 Read More »
Update: Prof. Fiona Watt – Executive chairwoman, Medical Research Council – has responded to The Times with an endorsement of the PACE Trial.
In a guest review, Dr Geraghty summarises his most recent study examining the BPS model in ME/CFS